This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
JPMorgan (JPM) Plans to Launch "JPM Coin" Using Blockchain
by Zacks Equity Research
JPMorgan (JPM) becomes the first U.S. bank to launch its own cryptocurrency "JPM Coin", using the blockchain technology.
Barclays (BCS) to Move Part of Derivatives Sales Jobs to Paris
by Zacks Equity Research
Barclays PLC (BCS) plans to shift some equity and credit derivatives sales jobs to Paris ahead of Brexit.
ICICI Bank (IBN) Jumps: Stock Rises 9.2%
by Zacks Equity Research
ICICI Bank (IBN) saw a big move last session, as its shares jumped more than 9% on the day, amid huge volumes.
ICICI Bank (IBN) Stock Up 9.2% Despite Lower Q3 Earnings
by Zacks Equity Research
Rise in expenses hurts ICICI Bank's (IBN) fiscal Q3 results. Nonetheless, improving credit quality, and increase in loans and deposits result in bullish investor sentiments.
May's Brexit Plan Defeat: Here Are the Winners & Losers
by Tirthankar Chakraborty
Here's a summary of some of the sectors and stocks in the United Kingdom that are gaining and losing from May's big Brexit deal loss.
Shoe Carnival, Diamondback Energy, HSBC, Northrup and Hitachi highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
Shoe Carnival, Diamondback Energy, HSBC, Northrup and Hitachi highlighted as Zacks Bull and Bear of the Day
Q4 Earnings Season Kicks Off: Global Week Ahead
by John Blank
Thirty-four S&P 500 firms release earnings over the coming week. Twenty-two of them will be financials.
Top Ranked Momentum Stocks to Buy for January 14th
by Zacks Equity Research
Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, January 14th
Deutsche Bank to Reexamine Details of 20,000 Risky Clients
by Zacks Equity Research
Deutsche Bank (DB) receives a deadline of June-end by the German regulator to complete the evaluation of risky clients.
Can Apple Survive a Prolonged U.S.-China Trade War?
by Zacks Equity Research
Apple's dependence on iPhone sales has posed a major problem for the iPhone maker in the Chinese market.
UBS Group AG Gets Nod to Boost Majority Stake in China JV
by Zacks Equity Research
UBS Group AG (UBS) receives approval to increase majority stake to 51% in its Chinese joint venture.
U.K. Stress Test Results: Can Banks Survive No-Deal Brexit?
by Nikita Kataruka
Per the U.K. stress test results, the Bank of England claims that British banks will be able to withstand even a disorderly Brexit.
Why is it a Wise Decision to Hold on to HSBC Stock for Now?
by Zacks Equity Research
While HSBC's (HSBC) efforts to improve market share in the U.K. and China, and strengthen digital capabilities globally, are expected to increase its exposure in the emerging markets, it is likely to lead to higher expenses.
Big Banks in Murky Waters, Now Accused for FX Manipulation
by Zacks Equity Research
Big global banks in trouble again with the filing of the latest lawsuit by a group of large institutional investors alleging the financial firms for rigging prices in the foreign exchange market.
SMFG vs. HSBC: Which Stock Is the Better Value Option?
by Zacks Equity Research
SMFG vs. HSBC: Which Stock Is the Better Value Option?
Top Analyst Reports for Amazon, Facebook, Mastercard & Merck
by Mark Vickery
Today's Research Daily features new research reports on 17 major stocks, including Amazon (AMZN), Facebook (FB), Mastercard (MA) and Merck (MRK).
HSBC Q3 Pre-Tax Earnings Up on Higher Revenues, Costs Rise
by Zacks Equity Research
HSBC's (HSBC) third-quarter results benefit from higher revenues, partly offset by rise in costs.
Barclays (BCS) Earnings and Revenues Increase Y/Y in Q3
by Zacks Equity Research
Barclays' (BCS) third-quarter results benefit from higher revenues, partly offset by rising expenses.
The Zacks Analyst Blog Highlights: Altria, U.S. Bancorp, Biogen, Ecolab and HSBC
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Altria, U.S. Bancorp, Biogen, Ecolab and HSBC
Top Analyst Reports for Altria, U.S. Bancorp & Biogen
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Altria (MO), U.S. Bancorp (USB) and Biogen (BIIB).
5 Reasons to Add Capital One (COF) Stock to Your Portfolio
by Zacks Equity Research
Capital One's (COF) solid revenue prospects, inorganic growth strategy, robust credit card operation and online banking business are likely to continue supporting profitability.
UBS Group Choses Frankfurt as Operations Hub Post Brexit
by Zacks Equity Research
UBS Group will be expanding its operations in Frankfurt, Madrid, Paris and Milan as part of its multi-location strategy.
Deutsche (DB) to Shift Large Portion of Assets From London
by Zacks Equity Research
Deutsche Bank (DB) remains on track to remodel its business in order to improve financials. However, shifting of assets from London might be a time consuming and an expensive affair.
Barclays (BCS) Plans to Add 150 Jobs in Europe Post Brexit
by Zacks Equity Research
As part of its Brexit plans, Barclays (BCS) to hire 150 people in Europe in addition to 150 current U.K. jobs, which are likely to shift to Dublin, post Brexit.
HSBC to Add 700 Staff and Double Client Assets in Asia Unit
by Zacks Equity Research
HSBC Holdings (HSBC) to employ nearly 700 people and double client assets in the Asia private banking unit, with an aim to grow business in the region.